Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.72
+0.22 (2.59%)
At close: Jul 27, 2026
Svas Biosana Market Cap
Svas Biosana has a market cap or net worth of €45.54 million as of July 27, 2026. Its market cap has increased by 4.27% in one year.
Market Cap
45.54M
Enterprise Value
84.62M
Revenue
141.56M
Ranking
n/a
PE Ratio
6.74
Stock Price
€8.72
ChartMarket Cap Chart
Since December 9, 2021, Svas Biosana's market cap has decreased from 81.14M to 45.54M, a decrease of -43.87%. That is a compound annual growth rate of -11.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 45.54M | 7.14% |
| Dec 30, 2025 | 42.51M | 10.91% |
| Dec 30, 2024 | 38.33M | -11.25% |
| Dec 29, 2023 | 43.19M | -20.87% |
| Dec 30, 2022 | 54.58M | -37.13% |
| Dec 30, 2021 | 86.80M | 6.97% |
| Dec 9, 2021 | 81.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.45B |
| DiaSorin | 3.54B |
| Amplifon | 2.93B |
| EL.En. | 1.25B |
| GPI S.p.A. | 394.04M |
| Talea Group | 40.74M |
| Arterra Bioscience | 20.24M |
| Helyx Industries | 18.91M |